Atlas Trials

The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens

Clinical trial NCT02413021 · UNKNOWN

Trial details

NCT number
NCT02413021
Sponsor
Isfahan University of Medical Sciences
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Lymphoid Leukemia
Start date
2016-05-01
Primary completion
2016-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.